AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21414133 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (males vs females)
Number of subjects: 40
Study 21414133 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless procedure
Number of subjects: 40
Study 21381321 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately intensive physical exercises during a long period
Number of subjects: 0
Study 17697901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine fast-dissolving tablet 20 mg
Number of subjects: 36
Study 17697901 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine capsule 5 mg
Number of subjects: 36
Study 17697901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 15889392 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot-deck (HD) multiple imputation using predictive mean matching for item non-response and approximate Bayesian bootstrap for unit non-response
Number of subjects: 0
Study 15889392 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate normal (MVN) model using PROC MI in SAS software V8.2
Number of subjects: 0
Study 15889392 — intervention group
Group type: COMPARATOR
Intervention: Last observation carried forward (LOCF) technique
Number of subjects: 0
Study 15889392 — intervention group
Group type: COMPARATOR
Intervention: Available-case (AC) analysis
Number of subjects: 0
Study 10675060 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous or dashed edge lines on experimental roads
Number of subjects: 0
Study 10675060 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving test on experimental roads
Number of subjects: 0
Study 10675060 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental roads
Number of subjects: 0
Study 10675060 — intervention group
Group type: COMPARATOR
Intervention: Unlined control road
Number of subjects: 0
Study 10675060 — intervention group
Group type: EXPERIMENTAL
Intervention: Edge-lined roads
Number of subjects: 0
Study 9282970 — intervention group
Group type: EXPERIMENTAL
Intervention: Decorin expression in healing gastric ulcers
Number of subjects: 18
Study 9282970 — intervention group
Group type: EXPERIMENTAL
Intervention: Biglycan expression in healing gastric ulcers
Number of subjects: 18
Study 9282970 — intervention group
Group type: COMPARATOR
Intervention: Normal gastric tissue
Number of subjects: 18
Study 8117902 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantel-Haenszel test for grouped failure time data (MHF test)
Number of subjects: 0
Study 8117902 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the number of subintervals in the MHF test
Number of subjects: 0
Study 8117902 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of frequency and actual times of measurement
Number of subjects: 0
Study 8117902 — intervention group
Group type: EXPERIMENTAL
Intervention: Power under exponential failure and censoring models
Number of subjects: 0
Study 3578948 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh gas flow of 482.5 +/- 186.6 ml X min‐1 (Group A)
Number of subjects: 60
Study 3578948 — intervention group
Group type: COMPARATOR
Intervention: Fresh gas flow of 2000 ml X min‐1 (Group B)
Number of subjects: 60
Study 3578948 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh gas flow adjusted to 7145 +/- 986 ml X min‐1 (Group C)
Number of subjects: 60
Study 31188081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower vitamin B6 intake (tertile 1) in total population
Number of subjects: 3362
Study 31188081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower vitamin B6 intake (tertile 1) in women
Number of subjects: 3362
Study 29068904 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care Teams (PCTeams)
Number of subjects: 5830
Study 29068904 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 5830
Study 29068904 — intervention group
Group type: COMPARATOR
Intervention: Nonrandomized Control
Number of subjects: 5830
Study 26824527 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg tamsulosin alone
Number of subjects: 118
Study 26824527 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg tamsulosin with 0.5 mg dutasteride daily for 12 months
Number of subjects: 118
Study 23275019 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenously administered golimumab
Number of subjects: 0
Study 23275019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21641522 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy at 10,000 lux
Number of subjects: 0
Study 21641522 — intervention group
Group type: COMPARATOR
Intervention: Usual standard of care and light therapy at 50 lux
Number of subjects: 0
Study 18047629 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.0 mL (Group A)
Number of subjects: 120
Study 18047629 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.2 mL (Group B)
Number of subjects: 120
Study 18047629 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.4 mL (Group C)
Number of subjects: 120
Study 18047629 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.6 mL (Group D)
Number of subjects: 120
Study 17195601 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroscience strategies applied in psychological treatment research
Number of subjects: 0
Study 14998900 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure therapy
Number of subjects: 52
Study 14998900 — intervention group
Group type: COMPARATOR
Intervention: Skills training
Number of subjects: 52
Study 11938860 — intervention group
Group type: EXPERIMENTAL
Intervention: Yinchen Dandao decoction (YCDDD) administered orally for 1 week starting 3 days after operation
Number of subjects: 60
Study 11938860 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 60
Study 9080642 — intervention group
Group type: EXPERIMENTAL
Intervention: Deslorelin (2.2 mg, subcutaneously as a short-term implant)
Number of subjects: 272
Study 8401637 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy following radical cystectomy
Number of subjects: 0
Study 8401637 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy following cystectomy or aggressive TUR
Number of subjects: 0
Study 3426824 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphocreatine (PC)
Number of subjects: 60
Study 3426824 — intervention group
Group type: COMPARATOR
Intervention: Control group (no phosphocreatine)
Number of subjects: 60
Study 29401241 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF) 60-64.8 Gy (25-27 fractions)
Number of subjects: 370
Study 29401241 — intervention group
Group type: COMPARATOR
Intervention: Standard fractionation (SF) 66-70 Gy (33-35 fractions)
Number of subjects: 370
Study 29401241 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF)
Number of subjects: 370
Study 29401241 — intervention group
Group type: COMPARATOR
Intervention: Standard fractionation (SF)
Number of subjects: 370
Study 25257752 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity RE at 20% of 1RM (LI)
Number of subjects: 24
Study 25257752 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity RE at 20% of 1RM combined with partial blood flow restriction (LI+BFR)
Number of subjects: 24
Study 25257752 — intervention group
Group type: COMPARATOR
Intervention: High-intensity RE at 80% of 1RM (HI)
Number of subjects: 24
Study 25346595 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-coded BP booklet for daily home BP measurement
Number of subjects: 121
Study 25346595 — intervention group
Group type: COMPARATOR
Intervention: Standard BP booklet
Number of subjects: 121
Study 23744819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.3 mg kg(‐1) i.v.
Number of subjects: 50
Study 23744819 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 50
Study 20593151 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU daily vitamin D
Number of subjects: 120
Study 20593151 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU daily vitamin D
Number of subjects: 120
Study 20593151 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU bolus every two months
Number of subjects: 120
Study 19128711 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Rhino (RR) nasal pack
Number of subjects: 51
Study 19128711 — intervention group
Group type: COMPARATOR
Intervention: Merocel nasal pack
Number of subjects: 51
Study 21169165 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet version of the Beck Depression Inventory (BDI-II)
Number of subjects: 87
Study 21169165 — intervention group
Group type: COMPARATOR
Intervention: Paper version of the Beck Depression Inventory (BDI-II)
Number of subjects: 87
Study 21169165 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet version of the Montgomery-Åsberg Depression Rating Scale-Self-rated (MADRS-S)
Number of subjects: 87
Study 21169165 — intervention group
Group type: COMPARATOR
Intervention: Paper version of the Montgomery-Åsberg Depression Rating Scale-Self-rated (MADRS-S)
Number of subjects: 87
Study 16238764 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding skills training programme (3 hours of in-service classes and 1 hour of hands-on training)
Number of subjects: 67
Study 16238764 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding skills training programme
Number of subjects: 67
Study 16238764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 67
Study 11964551 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir (1200 mg orally)
Number of subjects: 6
Study 11964551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 9485556 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (third dose)
Number of subjects: 18
Study 7803948 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine combined with cisplatin
Number of subjects: 600
Study 7803948 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine as second-line chemotherapy
Number of subjects: 600
Study 7803948 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine plus doxorubicin
Number of subjects: 600
Study 7803948 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 600
Study 7803948 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine (oral dosage form)
Number of subjects: 600
Study 3280092 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact laser cholecystectomy
Number of subjects: 21
Study 3280092 — intervention group
Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 21
Study 31990424 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg once daily (V20)
Number of subjects: 30
Study 31990424 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 40 mg twice daily (R40)
Number of subjects: 30
Study 28536873 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring in Chaos (CiC) BPT model
Number of subjects: 161
Study 28536873 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 161
Study 27037981 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse technique
Number of subjects: 42
Study 27037981 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal technique
Number of subjects: 42
Study 27037981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 42
Study 24709987 — intervention group
Group type: EXPERIMENTAL
Intervention: Attractive proposers (same sex)
Number of subjects: 0
Study 24709987 — intervention group
Group type: EXPERIMENTAL
Intervention: Less attractive proposers (same sex)
Number of subjects: 0
Study 24709987 — intervention group
Group type: EXPERIMENTAL
Intervention: Male proposers
Number of subjects: 0
Study 24709987 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasonableness of offers
Number of subjects: 0
Study 24709987 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to punish
Number of subjects: 0
Study 23730723 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling to support physical activity (n = 106)
Number of subjects: 192
Study 23730723 — intervention group
Group type: COMPARATOR
Intervention: Contact control (n = 86)
Number of subjects: 192
Study 20401354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) alone or in conjunction with conservative treatment
Number of subjects: 6
Study 20401354 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) prior to conservative treatment
Number of subjects: 6
Study 20401354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) combined with biofeedback, conservative treatment, and/or self-care
Number of subjects: 6
Study 17976727 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity assessment
Number of subjects: 294
Study 17976727 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 294
Study 17976727 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of visual function
Number of subjects: 294
Study 16293806 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumen (0.1% barium suspension), 1200 mL over 30 minutes
Number of subjects: 60
Study 16293806 — intervention group
Group type: COMPARATOR
Intervention: Control group (water and methylcellulose solution), 1200 mL over 30 minutes
Number of subjects: 60
Study 14525748 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for domestic violence using a brief verbal screen by existing ED personnel.
Number of subjects: 339
Study 14525748 — intervention group
Group type: EXPERIMENTAL
Intervention: ED-based advocacy program.
Number of subjects: 339
Study 14525748 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 339
Study 11027455 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908‐htrA(pTETlpp)
Number of subjects: 21
Study 11027455 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908‐htrA(pTETnir15)
Number of subjects: 21
Study 11027455 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908‐htrA(pTETlpp) and CVD 908‐htrA(pTETnir15)
Number of subjects: 21
Study 8889711 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% Intralipid emulsions of amphotericin B (ILA)
Number of subjects: 37
Study 1676779 — intervention group
Group type: EXPERIMENTAL
Intervention: TPGS (d‐alpha‐tocopheryl‐polyethylene‐glycol‐1000 succinate) 25 mg/kg daily
Number of subjects: 7
Study 1676779 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 7
Study 6352631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 59
Study 6352631 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 59
Study 29320594 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline hydrochloride cream 1.0% applied once daily for 29 days
Number of subjects: 440
Study 29320594 — intervention group
Group type: COMPARATOR
Intervention: Vehicle applied once daily for 29 days
Number of subjects: 440
Study 29320594 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline hydrochloride cream 1.0%
Number of subjects: 440
Study 29320594 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 440
Study 27367876 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg)
Number of subjects: 372
Study 27367876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study 24322569 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT)
Number of subjects: 53452
Study 24322569 — intervention group
Group type: COMPARATOR
Intervention: Chest radiography (CXR)
Number of subjects: 53452
Study 22034656 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 μg p.o.)
Number of subjects: 16
Study 22034656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 20837834 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention with standard care
Number of subjects: 151
Study 20837834 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 151
Study 18221408 — intervention group
Group type: EXPERIMENTAL
Intervention: G12 (12 weeks therapy)
Number of subjects: 45
Study 18221408 — intervention group
Group type: EXPERIMENTAL
Intervention: G24 (24 weeks therapy)
Number of subjects: 45
Study 18221408 — intervention group
Group type: EXPERIMENTAL
Intervention: G36 (36 weeks therapy)
Number of subjects: 45
Study 18221408 — intervention group
Group type: EXPERIMENTAL
Intervention: G48 (48 weeks therapy)
Number of subjects: 45
Study 15739210 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO (carbohydrate-rich drink) 50 kcal/100 ml, 290 mOsm/kg; 800 ml evening before surgery and 400 ml 2 hours before anaesthesia
Number of subjects: 172
Study 15739210 — intervention group
Group type: COMPARATOR
Intervention: Placebo; 800 ml evening before surgery and 400 ml 2 hours before anaesthesia
Number of subjects: 172
Study 15739210 — intervention group
Group type: COMPARATOR
Intervention: Fasted group; no intake before surgery
Number of subjects: 172
Study 15739210 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO (carbohydrate-rich drink)
Number of subjects: 172
Study 15087294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 microM)
Number of subjects: 34
Study 15087294 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg/day for 7 days)
Number of subjects: 34
Study 15087294 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (HDAC enhancer)
Number of subjects: 34
Study 15087294 — intervention group
Group type: COMPARATOR
Intervention: Histone acetylation status in AMs
Number of subjects: 34
Study 11300174 — intervention group
Group type: EXPERIMENTAL
Intervention: School dental screening
Number of subjects: 2321
Study 11300174 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 2321
Study 11300174 — intervention group
Group type: COMPARATOR
Intervention: High employed group
Number of subjects: 2321
Study 11300174 — intervention group
Group type: COMPARATOR
Intervention: Unemployed group
Number of subjects: 2321
Study 9309457 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID (600 mg of Sulindac for one day)
Number of subjects: 10
Study 9309457 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (transdermal system 50 micrograms/d, twice a week, Systen) for 3 months
Number of subjects: 10
Study 9309457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7823005 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptilose-ORS
Number of subjects: 134
Study 7823005 — intervention group
Group type: COMPARATOR
Intervention: WHO-ORS
Number of subjects: 134
Study 2943820 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (Preferid) applied under occlusion for 2, 24, and 48 h
Number of subjects: 19
Study 2943820 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone, hydrocortisone-butyrate (Locoid), budesonide (Preferid), and klobetasol (Dermovat) applied under occlusion for 1 h
Number of subjects: 19
Study 2943820 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 50 mg i.v. pretreatment
Number of subjects: 19
Study 2943820 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle) applied under occlusion
Number of subjects: 19
Study 29175724 — intervention group
Group type: EXPERIMENTAL
Intervention: Right amygdalohippocampectomy (AHE) patients
Number of subjects: 3
Study 29175724 — intervention group
Group type: COMPARATOR
Intervention: Proxies of AHE patients
Number of subjects: 3
Study 27629576 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-poor diet
Number of subjects: 52
Study 27629576 — intervention group
Group type: COMPARATOR
Intervention: Gluten-rich diet
Number of subjects: 52
Study 27629576 — intervention group
Group type: COMPARATOR
Intervention: Self-reported gluten intake
Number of subjects: 52
Study 24573971 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (0.5 mg/kg)
Number of subjects: 200
Study 24573971 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium (0.15 mg/kg)
Number of subjects: 200
Study 24573971 — intervention group
Group type: COMPARATOR
Intervention: Cisatracurium (0.03 mg/kg)
Number of subjects: 200
Study 24573971 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 200
Study 22945403 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (280 mg docosahexaenoic acid and 110 mg eicosapentaenoic acid)
Number of subjects: 420
Study 22945403 — intervention group
Group type: COMPARATOR
Intervention: Control (olive oil)
Number of subjects: 420
Study 20164363 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO diet (30% fat, 55% carbohydrate)
Number of subjects: 97
Study 20164363 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA diet (38% fat, 20% SFA)
Number of subjects: 97
Study 20164363 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet (38% fat, 22% MUFA)
Number of subjects: 97
Study 20164363 — intervention group
Group type: COMPARATOR
Intervention: All diets
Number of subjects: 97
Study 18682511 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide after prior treatment with risedronate
Number of subjects: 0
Study 18682511 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide after prior treatment with alendronate
Number of subjects: 0
Study 15885613 — intervention group
Group type: EXPERIMENTAL
Intervention: Observable signs and symptoms assessment by trained police officers
Number of subjects: 0
Study 15885613 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of specific impairing drugs
Number of subjects: 0
Study 12817157 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (mean daily dose 2 mg, range 0.5-4 mg) added to mood stabilizers
Number of subjects: 108
Study 10440305 — intervention group
Group type: EXPERIMENTAL
Intervention: Live, attenuated human rotavirus vaccine 89-12 (1x10^5 plaque-forming units)
Number of subjects: 215
Study 10440305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 10440305 — intervention group
Group type: EXPERIMENTAL
Intervention: Live, attenuated human rotavirus vaccine 89-12
Number of subjects: 215
Study 7825537 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy formula with added selenate (SF+Se, 0.17 mumol Se/L)
Number of subjects: 33
Study 7825537 — intervention group
Group type: COMPARATOR
Intervention: Soy formula (SF, 0.028 mumol Se/L)
Number of subjects: 33
Study 7825537 — intervention group
Group type: COMPARATOR
Intervention: Soy formula (SF)
Number of subjects: 33